Third Rock Ventures II, L.P.

Insider Reports History

Location
Boston, MA
Signature
/s/ Kevin Gillis, Chief Operating Officer of TRV GP II, LLC, general partner of Third Rock Ventures GP II, L.P., general partner of Third Rock Ventures II, L.P.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Third Rock Ventures II, L.P.:

Company Role Class Num Shares Value Price $ Report Date Ownership
Jounce Therapeutics, Inc. 10%+ Owner Common Stock 3,048,780 $5,640,243 $1.85 15 Sep 2021 Indirect
Jounce Therapeutics, Inc. 10%+ Owner Common Stock 2,697,829 $4,990,984 $1.85 15 Sep 2021 Direct
Revolution Medicines, Inc. 10%+ Owner Common Stock 12,925 $348,975 $27.00 03 Jun 2021 Indirect
Revolution Medicines, Inc. 10%+ Owner Common Stock 0 $27.00 04 Jun 2021 Direct

Insider Reports Filed by Third Rock Ventures II, L.P.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000089924321036411-third-rock-ventures-ii-l-p-2021-09-15 Jounce Therapeutics, Inc. 15 Sep 2021 1 $0 4 10%+ Owner 17 Sep 2021, 16:15
/report/000089924321023555-third-rock-ventures-ii-l-p-2021-06-10 Jounce Therapeutics, Inc. 10 Jun 2021 1 $0 4 10%+ Owner 14 Jun 2021, 16:19
RVMD Revolution Medicines, Inc. 03 Jun 2021 2 -$16,406,962 4 10%+ Owner 07 Jun 2021, 18:10
RVMD Revolution Medicines, Inc. 25 May 2021 2 -$41,764,208 4 10%+ Owner 27 May 2021, 17:43
/report/000089924321020883-third-rock-ventures-ii-l-p-2021-05-25 Jounce Therapeutics, Inc. 25 May 2021 1 -$4,420,160 4 10%+ Owner 27 May 2021, 17:42